Enhanced corneal permeation and antimycotic activity of itraconazole against Candida albicans via a novel nanosystem vesicle

References

• Aggarwal D, Kaur IP. (2005). Improved pharmacodynamics of timolol maleate from a mucoadhesive niosomal ophthalmic drug delivery system. Int J Pharm 290:155–9
   PubMed Web of Science ®Google Scholar
• Ahuja M, Singh G, Majumdar DK. (2008). Effect of formulation parameters on corneal permeability of ofloxacin. Sci Pharm 76:505–14
   Google Scholar
• Alonso MJ. (2004). Nanomedicines for overcoming biological barriers. Biomed Pharmacother 58:168–72
   PubMed Web of Science ®Google Scholar
• Al-Badriyeh D, Neoh CF, Stewart K, Kong DCM. (2010). Clinical utility of voriconazole eye drops in ophthalmic fungal keratitis. Clin Ophthalmol 4:391–405
   PubMedGoogle Scholar
• Badawi AA, El-Nabarawi MA, El-Setouhy DA, Alsammit SA. (2011). Formulation and stability testing of itraconazole crystalline nanoparticles. AAPS PharmSciTech 12:811–20
   PubMed Web of Science ®Google Scholar
• Bourlais CL, Acar L, Zia H, et al. (1998). Ophthalmic drug delivery systems-recent advances. Prog Retin Eye Res 17:33–58
   PubMed Web of Science ®Google Scholar
• Centis V, Vermette P. (2008). Physico-chemical properties and cytotoxicity assessment of PEG-modified liposomes containing human hemoglobin. Colloids Surf B Biointerfaces 65:239–46
   PubMed Web of Science ®Google Scholar
• Cevc G, Blume G. (1992). Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochim Biophys Acta 1104:226–32
   PubMed Web of Science ®Google Scholar
• Chandraprakash KS, Udupa N, Pillai GK. (1994). Pharmacokinetic evaluation of surfactant vesicle entrapped methotrexate in tumour bearing mice. Int J Pharm 61:R1–3
   Web of Science ®Google Scholar
• Chandraprakash KS, Udupa N, Umadevi P, Pillai GK. (1993). Formulation and evaluation of methotrexate niosomes. Drug Dev Ind Pharm 19:1331–42
   Web of Science ®Google Scholar
• Chen Y, Lu Y, Zhong Y, et al. (2012). Ocular delivery of cyclosporine A based on glycerylmonooleate/poloxamer 407 liquid crystalline nanoparticles: preparation, characterization, in vitro corneal penetration and ocular irritation. J Drug Target 20:856–63
   PubMed Web of Science ®Google Scholar
• Darwhekar G, Jain DK, Choudhary A. (2012). Elastic liposomes for delivery of neomycin sulphate in deep skin infection. Asian J Pharm Sci 7:230–40
   Google Scholar
• Devaraj GN, Parakh SR, Devraj R, et al. (2002). Release studies on niosomes containing fatty alcohols as bilayer stabilizers instead of cholesterol. J Colloid Interface Sci 251:360–5
   PubMed Web of Science ®Google Scholar
• Draize JH, Woodard G, Calvery HO. (1944). Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J Pharmacol Exp Ther 82:377–90
   Web of Science ®Google Scholar
• Dunbar MJ, Pyle R, Boring J, McCoy C. (1983). Treatment of canine blastomycosis with ketoconazole. J Am Vet Med Assoc 182:156–7
   PubMed Web of Science ®Google Scholar
• El Zaafarany GM, Awad GAS, Holayel SM, Mortada ND. (2010). Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery. Int J Pharm 397:164–72
   PubMed Web of Science ®Google Scholar
• El-Ridy MS, Badawi AA, Safar MM, Mohsen AM. (2012). Niosomes as a novel pharmaceutical formulation encapsulating the hepatoprotective drug silymarin. IJPPS 4:549–59
   Google Scholar
• Fang JY, Yu SY, Wu PC, et al. (2001). In vitro skin permeation of estradiol from various proniosome formulations. Int J Pharm 215:91–9
   PubMed Web of Science ®Google Scholar
• Guinedi AS, Mortada ND, Mansour S, Hathout RM. (2005). Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide. Int J Pharm 306:71–82
   PubMed Web of Science ®Google Scholar
• Gupta PN, Mishra V, Rawat A, et al. (2005). Non-invasive vaccine delivery in transfersomes, niosomes and liposomes: a comparative study. Int J Pharm 293:73–82
   PubMed Web of Science ®Google Scholar
• Hagan M, Wright E, Newman M, et al. (1995). Causes of suppurative keratitis in Ghana. Br J Ophthalmol 79:1024–8
   PubMed Web of Science ®Google Scholar
• Hagigit T, Abdulrazik M, Valamanesh F, et al. (2012). Ocular antisense oligonucleotide delivery by cationic nanoemulsion for improved treatmentof ocular neovascularization: an in-vivo study in rats and mice. J Control Release 160:225–31
   PubMed Web of Science ®Google Scholar
• Hodges R, Legendre A, Adams L, et al. (1994). Itraconazole for the treatment of histoplasmosis in cats. J Vet Intern Med 8:409–13
   PubMed Web of Science ®Google Scholar
• Kakkar S, Kaur IP. (2011). Spanlastics – a novel nanovesicular carrier system for ocular delivery. Int J Pharm 413:202–10
   PubMed Web of Science ®Google Scholar
• Kerl M. (2003). Update on canine and feline fungal diseases. Vet Clin North Am Small Anim Pract 33:721–47
   PubMed Web of Science ®Google Scholar
• Khan KA. (1975). The concept of dissolution efficiency. J Pharm Pharmacol 27:48–9
   PubMed Web of Science ®Google Scholar
• Lee E, Balakrishnan P, Song CK, et al. (2010). Microemulsion-based hydrogel formulation of itraconazole for topical delivery. J Pharm Invest 40:305–11
   Google Scholar
• Lee EH, Kim A, Oh YK, Kim CK. (2005). Effect of edge activators on the formation and transfection efficiency of ultra deformable liposomes. Biomaterials 26:205–10
   PubMed Web of Science ®Google Scholar
• Legendre AM, Rohrbach B, Toal R, et al. (1996). Treatment of blastomycosis with itraconazole in 112 dogs. J Vet Intern Med 10:365–71
   PubMed Web of Science ®Google Scholar
• Levin L, Avery R, Shore J, et al. (1996). The spectrum of orbital aspergillosis: a clinicopathological review. Surv Ophthalmol 41:142–54
   PubMed Web of Science ®Google Scholar
• Li N, Zhuang C, Wang M, et al. (2009). Liposome coated with low molecular weight chitosan and its potential use in ocular drug delivery. Int J Pharm 379:131–8
   PubMed Web of Science ®Google Scholar
• Manzouri B, Vafidis G, Wyse R. (2001). Pharmacotherapy of fungal eye infections. Expert Opin Pharmacother 2:1849–57
   PubMedGoogle Scholar
• Matsuzaki Y, Tsujisawa T, Nishihara T, et al. (2013). Antifungal activity of chemotype essential oils from rosemary against Candida albicans. OJST 3:176–82
   Google Scholar
• Mishra D, Dubey V, Asthana A, et al. (2006). Elastic liposomes mediated transcutaneous immunization against Hepatitis B. Vaccine 24:4847–55
   PubMed Web of Science ®Google Scholar
• Mohanty B, Mishra SK, Majumdar DK. (2013). In vitro permeation characteristics of itraconazole from oil drops and ophthalmic ointment through excised goat and sheep corneas. JPBS 5:19–26
   Google Scholar
• Mokhtar M, Sammour OA, Hammad MA, Megrab NA. (2008). Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes. Int J Pharm 361:104–11
   PubMed Web of Science ®Google Scholar
• Mukherjee S, Ray S, Thakur RS. (2009). Design and evaluation of itraconazole loaded solid lipid nanoparticulate system for improving the antifungal therapy. Pakistan J Pharm Sci 22:131–8
   PubMed Web of Science ®Google Scholar
• Nakarani M, Misra AK, Patel JK, Vaghani SS. (2010). Itraconazole nanosuspension for oral delivery: formulation, characterization and in vitro comparison with marketed formulation. DARU 18:84–90
   PubMed Web of Science ®Google Scholar
• Nava G, Piñón E, Mendoza L, et al. (2011). Formulation and in vitro, ex vivo and in vivo evaluation of elastic liposomes for transdermal delivery of ketorolac tromethamine. Pharmaceutics 3:954–70
   PubMedGoogle Scholar
• Organization for Economic Cooperation and Development (OECD). (2002). Guidelines for the testing of chemicals No. 405: acute eye irritation/corrosion. Paris, France, 1–14
   Google Scholar
• Parthasarathi G, Udupa N, Umadevi P, Pillai GK. (1994). Niosome encapsulated of vincristine sulfate: improved anticancer activity with reduced toxicity in mice. J Drug Target 2:173–82
   PubMed Web of Science ®Google Scholar
• Peeters J, Neeskens P, Tollenaere JP, et al. (2002). Characterization of the interaction of 2-hydroxypropyl-b-cyclodextrin with itraconazole at pH 2, 4 and 7. J Pharm Sci 91:1414–22
   PubMed Web of Science ®Google Scholar
• Raja RAN, Pillai GK, Udupa N, Chandrashekar G. (1994). Anti-inflammatory activity of niosome encapsulated diclofenac sodium in arthritic rats. Indian J Pharmacol 26:46–8
   Google Scholar
• Rangasamy M, Ayyasamy B, Raju S, et al. (2008). Formulation and in vitro evaluation of niosome encapsulated acyclovir. J Pharm Res 1:163–6
   Google Scholar
• Ruckmani K, Sankar V. (2010). Formulation and optimization of zidovudine niosomes. AAPS PharmSciTech 11:1110–27
   Web of Science ®Google Scholar
• Saag MS, Dismukes WE. (1988). Azole antifungal agents: emphasis on new triazoles. Antimicrob Agents Chemother 32:1–8
   PubMed Web of Science ®Google Scholar
• Schatzlein A, Cevc G. (1995). Skin penetration by phospholipid vesicles, transfersomes, as visualized by means of the confocal laser scanning microscopy. In: Cevc C, Paltauf F, eds. Phospholipids, characterization, metabolism, and novel biological applications. Champaign, IL: AOCS Press, 191–209
   Google Scholar
• See J, Wong T, Yeo K. (1998). Trends in the pattern of blindness and major ocular diseases in Singapore and Asia. Ann Acad Med Singapore 27:540–6
   PubMedGoogle Scholar
• Shakeel F, Baboota S, Ahuja A, et al. (2007). Nanoemulsions as vehicles for transdermal delivery of aceclofenac. AAPS PharmSciTech 8:304–10
   Web of Science ®Google Scholar
• Shen J, Sun M, Ping Q, et al. (2010). Incorporation of liquid lipid in lipid nanoparticles for ocular drug delivery enhancement. Nanotechnology 21:025101
   PubMed Web of Science ®Google Scholar
• Sternberg YT. (1994). Preparation and properties of vesicles (niosomes) of Sorbian monoesters (Span 20,40,60,80) and a Sorbitan trimester (Span 85). Int J Pharm 105:1–6
   Web of Science ®Google Scholar
• Taboda J. (2000). Systemic mycoses. In: Ettinger S, Feldman E, eds. Textbook of veterinary internal medicine. Philadelphia: WB Saunders, 453–76
   Google Scholar
• Van den Bergh BAI, Bouwstra JA, Junginger HE, Wertz PW. (1999). Elasticity of vesicles affects hairless mouse skin structure and permeability. J Control Release 62:367–79
   PubMed Web of Science ®Google Scholar
• Wagh VD, Deshmukh OJ. (2012). Itraconazole niosomes drug delivery system and its antimycotic activity against Candida albicans. ISRN Pharm (2012) 653465. doi:10.5402/2012/653465
   Google Scholar
• Weiner ND, Williams N, Birch G, et al. (1989). Topical delivery of liposomally encapsulated interferon evaluated in a cutaneous herpes guinea pig model. Antimicrob Agents Chemother 33:1217–21
   PubMed Web of Science ®Google Scholar
• Wolf A. (1998). Histoplasmosis. In: Green C, ed. Infectious diseases of the dog and cat. Philadelphia: WB Saunders, 378–83
   Google Scholar
• Zheng W, Fang X, Wang L, Zhang Y. (2012). Preparation and quality assessment of itraconazole transfersomes. Int J Pharm 436:291–8
   PubMed Web of Science ®Google Scholar
• Whitcher J, Srinivasan M, Upadhyay M. (2001). Corneal blindness: a global perspective. Bull World Health Organ 79:214–21
   PubMed Web of Science ®Google Scholar
• Yohai R, Bullock J, Aziz A, Markert R. (1994). Survival factors in rhino-orbital cerebral mucormycosis. Surv Ophthalmol 39:3–22
   PubMed Web of Science ®Google Scholar